Healthcare Fund II Gp Llc Fairmount serves as Executive at Viridian Therapeutics, Inc.\DE, where they oversee executive responsibilities. Since joining the company, Healthcare Fund II Gp Llc Fairmount has executed 1 insider transactions totaling $10.0M, demonstrating a bullish approach to their equity position. Their most recent transaction on Oct 23, 2025 involved purchasing 454,545 shares valued at $10.0M.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Oct 23, 2025 | VRDN | $10.0M | Purchase | 454,545 | $22.00 | Discretionary |
Healthcare Fund II Gp Llc Fairmount currently holds 3,914,458 shares of Viridian Therapeutics, Inc.\DE (VRDN), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Healthcare Fund II Gp Llc Fairmount has been a net buyer of VRDN stock. They have purchased $10.0M and sold $0 worth of shares.
Healthcare Fund II Gp Llc Fairmount's most recent insider trade was on Oct 23, 2025, when they purchased 454,545 shares at $22.00 per share.
Get notified when new Form 4 filings are submitted